Endoscopic submucosal dissection to remove large colorectal lesions was performed safely and successfully in an outpatient setting, based on data from more than 600 patients. The widespread adoption ...

Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...

The clinicopathological characteristics of the patients in the two groups are shown in Table 1. The mean sizes of the lesions were 27.1 mm in the ESD group and 25.0 mm in the EMR group. The incidence ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

New data confirms younger and younger Americans are being diagnosed with colon cancer. The good news is new technology can remove early-stage cancers without surgery - but to catch it early, doctors ...